Today's Hours: 8:00am - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    Uwe M. Martens, editor.
    Contents:
    Erlotinib
    Lapatinib
    Regorafenib
    Crizotinib
    Cabozantinib: multi-kinase inhibitor of MET, AXL, RET, and VEGFR2
    Vemurafenib
    Trametinib (GSK1120212)-- Everolimus
    Vismodegib
    Larotrectinib (LOXO-101)
    Palbociclib, the first of a new class of cell cycle inhibitors
    Cobimetinib (GDC-0973, XL518)
    Lenvatinib: a tyrosine kinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET
    Afatinib
    Olaparib
    Gefitinib
    Alectinib
    Osimertinib .
    Digital Access Springer 2018
  • Book
    [L.I. Vasilenko, otvetstvennyĭ redaktor].
    Print 1989
  • Article
    Sandberg L, Blohmé I, Brynger H, Lindholm A, Gelin LE.
    Proc Eur Dial Transplant Assoc. 1977;14:277-84.
    The importance of HLA matching was studied for 319 primary cadaveric kidney transplantations during the period 1969-1976. During 1969-1972 the HLA match was the basis for recipient selection and most cases belonged to match grade 0 or 1. Graft survival was significantly better for match grade 0. Within match grade 1 cases with one foreign HLA B antigen had lower graft survival than cases with one foreign HLA A antigen, indicating the importance of the HLA B series. During 1973-1976 the HLA match was hardly considered in recipient selection. HLA matching during this period seemed to be of less importance, except for match grade 0 and the totally mismatched cases. When matching was performed for the HLA B series, it was found that graft survival was significantly improved when no or only one foreign HLA B antigen was present. The prognosis for cases with foreign HLA B antigen was significantly better during the later period.
    Digital Access Access Options